Johnson & Johnson (JNJ) is a good quality business scoring 65/100, with particular strength in capital allocation and management quality. The business has solid fundamentals but falls short of elite quality on some measures.
Johnson & Johnson shows a solid competitive position with solid gross margins of 67.6%. However, some vulnerability to competitive pressure suggests the moat, while present, may face challenges. The business earns above-average returns but lacks the exceptional durability of the strongest moats.
Johnson & Johnson demonstrates moderate pricing power. The company maintains healthy margins and has been able to grow revenue without significant margin compression. Encouragingly, margins have been expanding. This suggests reasonable, though not exceptional, ability to pass costs through to customers.
Johnson & Johnson has moderate predictability. Financial results have shown some volatility, with periods of uneven revenue or cash flow performance. While the business generates returns, forecasting its near-term trajectory requires more caution due to this variability.
Johnson & Johnson has a moderate financial position. Leverage is elevated but not critical. The balance sheet could face stress in an economic downturn. Management should prioritize debt reduction to strengthen the company's resilience.
Johnson & Johnson demonstrates excellent capital allocation, generating excellent returns on invested capital while reducing shares outstanding through buybacks. Management deploys capital at rates well above the cost of capital, creating significant value for shareholders.
The allocation between reinvestment, buybacks, and dividends appears disciplined and shareholder-friendly.
Johnson & Johnson's management team demonstrates strong execution, with stock-based compensation kept to just 1.3% of revenue. Consistent high returns on capital and stable operating margins indicate a team focused on operational excellence and long-term value creation rather than short-term metrics.

Is Johnson & Johnson a good investment at $244?
The following analysis is provided for informational and educational purposes only. It does not constitute financial advice, investment advice, or a recommendation to buy or sell any security. The opinions expressed are based on publicly available information and historical data. Beanvest and its contributors may hold positions in the securities mentioned. Investors should conduct their own due diligence or consult a licensed financial advisor before making any investment decision.